These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
82. Molecular controls of lymphatic VEGFR3 signaling. Deng Y; Zhang X; Simons M Arterioscler Thromb Vasc Biol; 2015 Feb; 35(2):421-9. PubMed ID: 25524775 [TBL] [Abstract][Full Text] [Related]
83. Targeting VE-PTP activates TIE2 and stabilizes the ocular vasculature. Shen J; Frye M; Lee BL; Reinardy JL; McClung JM; Ding K; Kojima M; Xia H; Seidel C; Lima e Silva R; Dong A; Hackett SF; Wang J; Howard BW; Vestweber D; Kontos CD; Peters KG; Campochiaro PA J Clin Invest; 2014 Oct; 124(10):4564-76. PubMed ID: 25180601 [TBL] [Abstract][Full Text] [Related]
84. Promotion of cell spreading and migration by vascular endothelial-protein tyrosine phosphatase (VE-PTP) in cooperation with integrins. Mori M; Murata Y; Kotani T; Kusakari S; Ohnishi H; Saito Y; Okazawa H; Ishizuka T; Mori M; Matozaki T J Cell Physiol; 2010 Jul; 224(1):195-204. PubMed ID: 20301196 [TBL] [Abstract][Full Text] [Related]
86. CD93 maintains endothelial barrier function and limits metastatic dissemination. Vemuri K; de Alves Pereira B; Fuenzalida P; Subashi Y; Barbera S; van Hooren L; Hedlund M; Pontén F; Lindskog C; Olsson AK; Lugano R; Dimberg A JCI Insight; 2024 Mar; 9(7):. PubMed ID: 38441970 [TBL] [Abstract][Full Text] [Related]
87. Heterogeneity of endothelial VE-PTP downstream polarization, Tie2 activation, junctional claudin-5, and permeability in the aorta and vena cava. Baluk P; Shirakura K; Vestweber D; McDonald DM Cell Tissue Res; 2024 Jan; 395(1):81-103. PubMed ID: 38032480 [TBL] [Abstract][Full Text] [Related]
88. An agonistic anti-Tie2 antibody suppresses the normal-to-tumor vascular transition in the glioblastoma invasion zone. Lee E; Lee EA; Kong E; Chon H; Llaiqui-Condori M; Park CH; Park BY; Kang NR; Yoo JS; Lee HS; Kim HS; Park SH; Choi SW; Vestweber D; Lee JH; Kim P; Lee WS; Kim I Exp Mol Med; 2023 Feb; 55(2):470-484. PubMed ID: 36828931 [TBL] [Abstract][Full Text] [Related]
89. Shear stress control of vascular leaks and atheromas through Tie2 activation by VE-PTP sequestration. Shirakura K; Baluk P; Nottebaum AF; Ipe U; Peters KG; McDonald DM; Vestweber D EMBO Mol Med; 2023 Apr; 15(4):e16128. PubMed ID: 36740996 [TBL] [Abstract][Full Text] [Related]
90. Extracellular Vesicles from Human Umbilical Cord-Derived MSCs Affect Vessel Formation In Vitro and Promote VEGFR2-Mediated Cell Survival. Muñiz-García A; Wilm B; Murray P; Cross MJ Cells; 2022 Nov; 11(23):. PubMed ID: 36497011 [TBL] [Abstract][Full Text] [Related]
91. Actin cytoskeleton in angiogenesis. Yadunandanan Nair N; Samuel V; Ramesh L; Marib A; David DT; Sundararaman A Biol Open; 2022 Dec; 11(12):. PubMed ID: 36444960 [TBL] [Abstract][Full Text] [Related]
93. Single-Cell Transcriptomics Reveal Disrupted Kidney Filter Cell-Cell Interactions after Early and Selective Podocyte Injury. Clark AR; Marshall J; Zhou Y; Montesinos MS; Chen H; Nguyen L; Chen F; Greka A Am J Pathol; 2022 Feb; 192(2):281-294. PubMed ID: 34861215 [TBL] [Abstract][Full Text] [Related]
94. Luo H; Zhang Y; Deng Y; Li L; Sheng Z; Yu Y; Lin Y; Chen X; Feng P Front Cell Dev Biol; 2021; 9():728821. PubMed ID: 34733844 [TBL] [Abstract][Full Text] [Related]
95. Growth Factor Deregulation and Emerging Role of Phosphatases in Diabetic Peripheral Artery Disease. Mercier C; Rousseau M; Geraldes P Front Cardiovasc Med; 2020; 7():619612. PubMed ID: 33490120 [TBL] [Abstract][Full Text] [Related]
96. PRL-2 phosphatase is required for vascular morphogenesis and angiogenic signaling. Poulet M; Sirois J; Boyé K; Uetani N; Hardy S; Daubon T; Dubrac A; Tremblay ML; Bikfalvi A Commun Biol; 2020 Oct; 3(1):603. PubMed ID: 33097786 [TBL] [Abstract][Full Text] [Related]